A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCGrefractory and BCG-intolerant patients.
一项 I 期研究，旨在评估膀胱内注射靶向 EpCAM 的免疫毒素治疗 BCG 难治性或 BCG 不耐受患者的非肌层浸润性膀胱癌的疗效
期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S14071
Kowalski Mark, Entwistle Joycelyn, Cizeau Jeannick, Niforos Demi, Loewen Shauna, Chapman Wendy, MacDonald Glen C
